XML 30 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation
 12 Months Ended
Jan. 29, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation:
Engility Acquisition Assumed Awards
Upon the acquisition of Engility, all Engility outstanding and unvested equity awards were converted into SAIC vesting stock awards using the same exchange ratio as Engility’s common shareholders (0.45 SAIC share per Engility share). The Company assumed approximately 642,000 converted vesting stock awards with a fair value of $65.03 per share for a total of $42 million, which was bifurcated between pre- and post-combination periods of service in the amount of $22 million and $20 million, respectively. The amount attributable to the pre-combination service period is included in the purchase consideration of Engility. Of the remaining $20 million attributable to the post-combination service period, the Company expensed $2 million, $3 million, and $14 million in fiscal 2021, fiscal 2020, and fiscal 2019, respectively.
Plan Summaries
Certain of the Company’s employees participate in the following four stock-based compensation plans: “2013 Equity Incentive Plan” (EIP), “Management Stock Compensation Plan,” “2013 Employee Stock Purchase Plan” (ESPP), and the "2012 Long Term Performance Plan" (LTPP) for Engility assumed awards, which are herein referred to together as the “Plans.” The Company issues new shares on the vesting of stock awards or exercise of stock options under these Plans.
The EIP provides the Company’s employees and directors the opportunity to receive various types of stock-based compensation and cash awards. The terms of the stock-based awards granted to employees and directors are the same, except that those for directors cliff vest within one year of the grant date. As of January 29, 2021, the Company has outstanding stock options, vested and vesting stock awards, and performance share awards under this plan. Stock options granted under the EIP generally become exercisable 33%, 33%, and 33% after one, two and three years, respectively, while vesting stock awards granted prior to fiscal 2020 generally vest 25%, 25%, 25% and 25% after one, two, three and four years, respectively. Vesting stock awards granted in fiscal 2020 and thereafter generally vest 33%, 33%, and 33% after one, two and three years, respectively. The maximum contractual term for stock options granted under the EIP is ten years, but historically the Company has granted stock options with a seven-year contractual term. Vesting may be accelerated for employees meeting retirement eligibility conditions. Vesting accelerates for eligible officers upon termination of employment, subject to certain conditions set forth in the Company’s Executive Severance, Change in Control and Retirement Policy effective July 1, 2020. Stock-based awards generally provide for accelerated vesting if there is a change in control (as defined in the EIP). Vesting stock awards and performance share awards have forfeitable rights to dividends. In June 2014, the EIP was amended and restated to increase the total authorized shares of common stock for issuance under the EIP from 5.7 million to 8.5 million.
The Company grants performance-based stock awards to certain officers and key employees under the EIP. Performance shares are rights to receive shares of the Company’s stock on the satisfaction of service requirements and performance conditions. These awards cliff vest at the end of the third fiscal year following the grant date, subject to meeting the minimum service requirements and the achievement of certain annual and cumulative financial metrics of the Company’s performance, with the number of shares ultimately issued, if any, ranging up to 200% of the specified target shares. If performance is below the minimum threshold level of performance, no shares will be issued. For all performance share awards granted, the annual financial metrics are based on operating cash flows and the cumulative financial metrics are based on a measure of earnings.
The Management Stock Compensation Plan provides for awards in share units to eligible employees. Benefits are payable in shares of the Company’s stock that are held in a trust for the purpose of funding benefit payments to the participants. During fiscal 2017 all remaining outstanding awards in the Management Stock Compensation Plan vested. The Board of Directors may at any time amend or terminate the Management Stock Compensation Plan. In the event of a change in control of the Company (as defined by the Management Stock Compensation Plan), participant accounts will be immediately distributed, otherwise participant accounts will generally be distributed upon retirement, based on the participant’s payout election, or upon termination. The Management Stock Compensation Plan does not provide for a maximum number of shares available for future issuance.
The Company’s ESPP allows eligible employees to purchase shares of the Company’s stock at a discount of up to 15% of the fair market value on the date of purchase. During the three years ended January 29, 2021, the discount was 5% of the fair market value on the date of purchase for purchases made under the Company’s ESPP, thereby resulting in the ESPP being non-compensatory. As of January 29, 2021, 3.4 million shares of the Company’s stock are authorized for issuance under the ESPP.
The LTPP provides certain employees of the Company the opportunity to receive various types of stock-based compensation awards. As of January 29, 2021, the Company has vesting stock awards assumed from the Engility acquisition under this plan. These remaining outstanding vesting stock awards assumed under the LTPP will continue to vest under their original vesting schedule, when granted by Engility prior to the acquisition, and generally cliff vest at the end of the third fiscal year following the grant date. Vesting may be accelerated for employees meeting retirement eligibility conditions. Vesting stock awards under the LTPP have forfeitable rights to dividends.
Expense and Related Tax Benefits Recognized
Stock-based compensation expense and related tax benefits recognized under the Plans were:
Year Ended
January 29,
2021		January 31,
2020		February 1,
2019
(in millions)
Stock-based compensation expense:
Stock options$3 $4 $3 
Vesting stock awards32 29 37 
Performance share awards7 4 5 
Total stock-based compensation expense$42 $37 $45 
Tax benefits recognized from stock-based compensation$14 $13 $20 
Stock Options
Stock options are granted with their exercise price equal to the closing market price of the Company’s stock on the last trading day preceding the grant date.
Stock option activity for the year ended January 29, 2021 was:
Shares of stocks under stock optionsWeighted-average exercise priceWeighted-average remaining contractual termAggregate intrinsic value
(in millions)(in years)(in millions)
Outstanding at January 31, 20200.7 $60.47 3.5$20 
Options granted0.2 74.57 
Options forfeited or expired— — 
Options exercised(0.2)40.82 
Outstanding at January 29, 20210.7 $68.57 3.9$20 
Options exercisable at January 29, 20210.5 $64.91 2.8$14 
Vested and expected to vest as of January 29, 20210.7 $68.48 3.8$19 
 
As of January 29, 2021 there was $2 million of unrecognized compensation cost, net of estimated forfeitures, related to stock options, which is expected to be recognized over a weighted-average period of 1.1 years.
The following table summarizes activity related to exercises of stock options:
Year Ended
January 29,
2021		January 31,
2020		February 1,
2019
(in millions)
Cash received from exercises of stock options$— $— $— 
Stock exchanged at fair value upon exercises of stock options$1 $2 $1 
Tax benefits from exercises of stock options$2 $3 $7 
Total intrinsic value of options exercised$8 $16 $24 
 
The fair value of stock option awards granted under the Company’s plan were valued using the Black-Scholes option-pricing model based on the following assumptions:
Expected Term--The expected term was calculated from the Company's historical settlement data.
Expected Volatility--The expected volatility is based on the historical volatility of the Company over a period commensurate with the expected term of the stock option as of the date of grant.
Risk-Free Interest Rate--The risk-free interest rate is based on the yield curve of a zero-coupon U.S. Treasury bond with a maturity equal to the expected term of the stock option on the date of grant.
Dividend Yield--The dividend yield assumed over the expected term of the option is calculated based on the most recently announced dividend as of the grant date.
The weighted-average grant date fair value and assumptions used to determine the fair value of stock options granted for the periods presented were:
Year Ended
January 29,
2021		January 31,
2020		February 1,
2019
Weighted-average grant-date fair value$17.54 $16.88 $19.48 
Expected term (in years)3.84.24.0
Expected volatility35.5 %30.0 %29.0 %
Risk-free interest rate0.3 %2.2 %2.5 %
Dividend yield1.8 %2.0 %1.6 %

Vesting Stock Awards
Vesting stock award activity for the year ended January 29, 2021 was:
Shares of stock under stock awardsWeighted-average grant date fair value
(in millions)
Unvested January 31, 20200.9 $74.94 
Awards granted0.6 76.41 
Awards forfeited(0.1)75.34 
Awards vested(0.4)72.64 
Unvested January 29, 20211.0 $76.73 
 
The grant date fair value of vesting stock awards is based on the closing market price of the Company’s stock on the last trading day preceding the grant date. The weighted-average grant date fair value of the vesting stock awards granted for fiscal 2021, fiscal 2020 and fiscal 2019 was $76.41, $76.01 and $84.28, respectively. As of January 29, 2021 there was $39 million of unrecognized compensation cost, net of estimated forfeitures, related to vesting stock awards, which is expected to be recognized over a weighted-average period of 1.3 years. The fair value of vesting stock awards that vested in fiscal 2021, fiscal 2020 and fiscal 2019 was $32 million, $35 million and $60 million, respectively.
Performance Share Awards
Performance share award activity for the year ended January 29, 2021 was:
Shares of stock under performance sharesWeighted-average grant date fair value
(in millions)
Unvested performance shares at January 31, 20200.1 $81.60 
Performance shares granted0.1 74.40 
Performance shares forfeited— — 
Performance shares vested— — 
Performance shares adjustment— — 
Unvested performance shares at January 29, 20210.2 $76.54 
 
For performance share awards granted in fiscal 2021, the actual number of shares to be issued upon vesting range between 0-200% of the specified target shares. For performance share awards granted prior to fiscal 2021, the actual number of shares to be issued upon vesting range between 0-150% of the specified target shares. The number of performance shares are presented at 100% of the specified target shares in the table above, except for performance shares that vested and performance shares adjustment. Performance shares vested reflects the number of shares to be issued based on the actual achievement of the performance goals for shares that vested during the period. Performance shares adjustment reflects the increase or decrease in the number of performance shares vested compared to the number of performance shares that would have vested at target.
The fair value of performance share awards that vested in fiscal 2021 was $5 million. For unvested performance shares as of January 29, 2021 the Company expects to issue 0.2 million shares of stock in the future based on estimated future achievement of the performance goals. The weighted-average grant date fair value of the performance share awards granted for fiscal 2021, fiscal 2020, and fiscal 2019 was $74.40, $79.04 and $85.31, respectively. The grant date fair value of performance share awards is based on the closing market price of the Company’s common stock on the last trading day preceding the grant date. As of January 29, 2021 there was $5.6 million of unrecognized compensation cost, net of estimated forfeitures, related to performance share awards, which is expected to be recognized over a weighted-average period of 1.7 years.